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ABSTRACT
Giardiasis is a common diarrheal disease caused by the protozoan parasite Giardia intestinalis.
Cysteine proteases (CPs) are acknowledged as virulence factors in Giardia but their speciﬁc role in
the molecular pathogenesis of disease is not known. Herein, we aimed to characterize the three
main secreted CPs (CP14019, CP16160 and CP16779), which were identiﬁed by mass spectrometry
in the medium during interaction with intestinal epithelial cells (IECs) in vitro. First, the CPs were
epitope-tagged and localized to the endoplasmic reticulum and cytoplasmic vesicle-like structures.
Second, we showed that recombinant CPs, expressed in Pichia pastoris, are more active in acidic
environment (pH 5.5-6) and we determined the kinetic parameters using ﬂuorogenic substrates.
Third, excretory-secretory proteins (ESPs) from Giardia trophozoites affect the localization of apical
junctional complex (AJC) proteins and recombinant CPs cleave or re-localize the AJC proteins
(claudin-1 and -4, occludin, JAM-1, b-catenin and E-cadherin) of IECs. Finally, we showed that the
ESPs and recombinant CPs can degrade several chemokines, including CXCL1, CXCL2, CXCL3, IL-8,
CCL2, and CCL20, which are up-regulated in IECs during Giardia-host cell interactions. This is the ﬁrst
study that characterizes the role of speciﬁc CPs secreted from Giardia and our results collectively
indicate their roles in the disruption of the intestinal epithelial barrier and modulating immune
responses during Giardia infections.
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Introduction
Giardia intestinalis (syn. Giardia duodenalis and Giardia
lamblia) is a protozoan parasite that colonizes the upper
small intestines of mammals and is a major cause of
waterborne diarrhea worldwide [1,2]. There are eight G.
intestinalis genotypes or assemblages designated from A
to H, of which parasites that belong to assemblages A or
B infect humans [3]. The cyst, acquired through the
oral-fecal route, is the infectious form of the parasite. It
breaks open in the duodenum and jejunum, releasing
excyzoites that quickly differentiate to trophozoites [1].
The trophozoites adhere to the apical surface of IECs
with an adhesive disc [4]. This close contact and subse-
quent interaction results in a succession of pathophysio-
logical changes, leading to diarrhea, malabsorption and
weight loss [5]. These outcomes manifest clearly in
immunocompromised or elderly people and in young
children of the developing world [6].
The intestinal epithelial barrier (IEB) works selectively
to separate the external environment of the intestinal
lumen from underlying host tissues and it is formed by
tight and adherens junctions (together known as apical
junctional complexes, AJCs) [7,8]. AJCs localize inter-
cellularly creating a seal to prevent the paracellular diffu-
sion of microorganisms and antigens across the
epithelium [7,8]. They are composed of transmembrane
proteins (e.g. claudins, occludin, junctional adhesion
molecules (JAMs)), cytosolic plaque proteins (zonula
occludens (ZO) family) and cytosolic regulatory proteins
(F-actin, a-actinin) [7]. A perijunctional acto-myosin
belt-like ring encircles the apical pole of epithelial cells
and it is tightly linked to AJCs. The acto-myosin ring
regulates the tight junction structure (e.g. claudins and
occludins) and paracellular permeability [9]. Giardia
increases intestinal epithelial permeability in human
patients and in experimentally infected mice [10,11].
The increased intestinal epithelial permeability is due to
AJC alterations, epithelial cell apoptosis and arginine
starvation [8]. Trophozoite attachment and excretory-
secretory products (ESPs) released during infection of
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IECs are believed to be responsible for the structural
changes seen in the AJCs [12–16].
Giardia ESPs contain several protease activities as deter-
mined by substrate impregnated SDS-PAGE or zymogram
gels and proteomics and the main activities belong to the
cysteine proteases (CPs) [17–19]. Accumulating data sug-
gest that giardial CPs are involved in disease induction
and pathogenesis [20]. BALB/c mice administered ESPs
orally exhibited signs of mucosal injury and developed spe-
ciﬁc humoral immune responses, which were less apparent
upon ESPs treatment with E-64, a CP-speciﬁc inhibitor
[21]. An increase in CP secretion has been seen during
host-parasite interactions in vitro [18]. It has been shown
that CPs can disrupt cellular junctions, compromising the
integrity of the IEB [22]. Recent reports have also shown
that CP activities from Giardia are able to induce cleavage
of the microvillus protein villin [23], cleave the chemokine
IL-8 and reduce inﬂammation [24], affect the bacterial
normal ﬂora and bioﬁlm formation [25,26] n and inhibit
the growth of intestinal bacterial pathogens [27]. Taken
together, these studies show an important role for CP
activities during host-Giardia interactions. However, the
roles of CPs in Giardia’s pathogenicity have been investi-
gated using cell extracts and/or CP inhibitors but the func-
tion of speciﬁc CPs from Giardia in the disease
mechanism(s) requires further investigations.
The CPs are the most prevalent types of proteases in
the Giardia WB genome; totally 26 genes with 9 cathep-
sin B-like, 4 cathepsin C-like and 13 cathepsin K/L-like
genes [28,29]. The cathepsin B-like proteases are the
most highly expressed cathepsins and many are up-regu-
lated during differentiation and Giardia-IEC interactions
in vitro [30–35]. Speciﬁc CPs have been suggested to be
involved in excystation (CP1 or CP10217, CP2 or
CP14019 and CP3 or CP16779) [36], encystation
(CP14109) [29] and degradation of endocytosed proteins
(CP14019) [37].
The aim of this study was to identify the major
secreted Giardia CPs during interaction with IECs and
to study their roles during Giardia infections. Based on
earlier reports of giardial CP activities during host-para-
site interactions we hypothesized that the proteolytic
activity of the CPs disrupts the AJCs and enables the CPs
to pass through the intestinal barrier so they can degrade
the chemokines produced by IECs.
Results
Indentiﬁcation of secreted cysteine proteases by
gelatin zymogram gels and mass spectrometry
Several earlier studies have reported CP activities as part
of Giardia ESPs on zymogram gels but the speciﬁc
proteases have never been identiﬁed [17–19]. We have
recently identiﬁed several giardial and human CPs in the
culture supernatant during Giardia host-cell interactions
using LC-MS/MS (Table S1) [38]. Here we decided to
complement this by identifying the main secreted CPs on
zymogram gels, especially the activities that increase dur-
ing host-parasite interactions [18]. Secreted proteins of
Giardia trophozoites (human isolate WB, assemblage A)
were collected in a serum-free medium for 2 h and 6 h in
the presence or absence of differentiated Caco-2 cells and
separated on zymogram gels to detect protease activities.
Analyses of the zymogram gels revealed proteolysis bands
with molecular weights ranging from 20–200 kDa (Fig. 1),
amongst which proteases of 60–100 kDa exhibited the
most pronounced proteolytic activity. In the absence of
Caco-2 cells, proteolytic activities were more pronounced
in samples collected from 2 h of incubation and some
bands around 20 kDa are slightly inhibited by treatment
with the cysteine protease inhibitor E64 (Fig. 1A). In the
presence of Caco-2 cells (Fig. 1B), proteolytic patterns
were similar to those in axenic culture samples, but the
intensities of all bands were stronger, suggesting an
increase in the proteolytic activity upon incubation with
host cells. We also noticed the appearance of new bands
around 30–35 kDa in molecular weight during the inter-
action (Fig. 1B). The activities are not inhibited by E64
and it is most likely one or several of the released human
proteases (Table S1) since it can be seen when only Caco-
2 cells are analyzed. The proteolytic activity of the bands
around 20 kDa was signiﬁcantly inhibited when ESPs
from co-culture with either Giardia isolate were treated
with E64 (Fig. 1B). These bands were excised from the
non-E64 treated lane (Fig. 1B) of the WB trophozoite-
host cell interaction and analyzed using mass spectrometry
(Materials and Methods). This identiﬁed a few tryptic
peptides that belong to three giardial clan CA cathepsin
B-like CPs: CP1 to CP3 or CP10217, CP14019, and
CP16779 (Table S2). It should be noted that one peptide
(N-NSWGPDWGEDGYFR-C) can be found in both
CP14019 and CP16779, but also in another CP, CP16160.
Thus, it is possible that CP16160 is also secreted. This has
been veriﬁed in our recent proteomics study of giardial
ESPs where CP14019, CP16160 and CP16779, were found
to be the main CPs released during the interaction
between trophozoites and IECs (Table S1) [38].
Expression and localization of the secreted CPs
There are 8 genes in the WB genome that encode clan
CA cathepsin B-like CPs with a mature size of 20–
25 kDa [29]. The genes encoding the four identiﬁed
secreted CPs localize to chromosomes 1 (10217), 3
(CP16160) and 4 (CP14109 and 16779) in the G.
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intestinalis WB isolate (www.giardiadb.org) and they can
be found in syntenic regions in parasites from assemb-
lages B (GS isolate) and E (P15 isolate). All proteins have
predicted signal- and propeptides but the N terminal of
CP16160 in the WB genome is most likely wrongly
annotated and should start with MIGASLLLGAV (www.
giardiadb.org). CP14019 shows 80% identity to CP16779
and 50% identity to CP10217 and CP16160. The struc-
tures of the pro- and mature proteases were predicted
using iTasser and Phyre2 and the structural models
aligned well with known cathepsin B structures (Fig. S1
to S3, Table S3 to S5). CP10217, CP14019 and CP16779
are most similar to Trypanosoma congolese procathepsin
(PDB: 5FPW), whereas CP16160 is more similar to the
human procathepsin B (PDB: 7PCK). A conserved cyste-
ine (position 26 in CP16160) and histidine (position 165
in CP16160), predicted to be 3.7A

apart in a hydropho-
bic pocket on one side of the protein, most likely make
up the catalytic dyad of the enzymes (Fig. S4). Expression
data shows that the four CPs are among the most highly
expressed genes in Giardia trophozoites and expression
increases in encystation [39]. Interestingly, CP14109 and
CP16779 are up-regulated at the RNA level upon host
cell contact [30–32] and CP16160 is more highly
expressed at the protein level in virulent Giardia strains
[34]. Earlier studies have localized CP14019 and
CP10217 to the ER and cytoplasmic vesicles, using GFP
fusions and polyclonal antibodies [37,39]. We produced
transfectant cell lines expressing C-terminally epitope-
tagged constructs of the three cysteine proteases
CP16779, CP14019 and CP16160 in G. intestinalis and
imaged them by immunoﬂuorescence microscopy. The
results showed that all three proteins localized to an ER-
like and punctuate vesicle-like structures within the cyto-
plasm (Fig. 2), similar to what has been seen earlier with
CP14019 and CP10217 [37,39]. Thus, all four CPs local-
ize to the same cellular structures in Giardia tropho-
zoites.
Characterization of recombinant CP14019, CP16160
and CP16779
We decided to characterize CP14019, CP16160 and
CP16779 further since they have interesting expression pat-
terns during differentiation, host cell interactions and in vir-
ulent strains (see above). The three CPs were expressed in P.
pastoris and puriﬁed using Ni-columns that bind the poly-
histidine-tag in the recombinant proteins (Fig. 3A). The
recombinant CP14019 and CP16779 were found to be auto-
activated to the mature form (28 kDa) during the puriﬁca-
tion process (Fig. 3A), whereas the expressed CP16160 was
found in two forms, 28 kDa and 37 kDa, during puriﬁcation
Figure 1. Detection of G. intestinalis secreted proteases in the culture supernatant of trophozoites grown alone or in interaction with
Caco-2 cell monolayers. Samples of medium were collected after 2 h and 6 h incubation of WB trophozoites at 37C in DMEM in the
absence (A) and presence (B) of Caco-2 monolayer, respectively. The presence of cysteine proteases was detected in concentrated cul-
ture supernatants from both axenic and co-cultures by using E64 to inhibit the activities of cysteine protease. For E64 pretreated sam-
ples, 100 mM of E64 was used in pre-incubation with ES products at 37C for 30 min before the electrophoresis. The protein ladders are
indicated on the left (kDa).
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but the proenzyme auto-cleaved to the mature form
(28 kDa) after 2 hours incubation in a sodium acetate buffer
(pH 5.5) (Fig. 3A).
To measure the activity of mature enzymes, the activ-
ity proﬁle of each recombinant enzyme was examined
against the artiﬁcial substrates Z-FR-AMC and Z-RR-
AMC that were used earlier with CP14019 [29]. All CPs
were found to be more active under acidic condition.
Speciﬁcally, the optimal pH for CP14019 and CP16779
was found to be 5.5 and 6, respectively, for both sub-
strates (Fig. 3B and C, Fig. S5) whereas CP16160 cleaved
Z-FR-AMC at an optimal pH of 6.0 and Z-RR-AMC at a
pH of 5.5 (Fig. 3D, Fig. S5). We then measured the
kinetic parameters of the enzymes against Z-FR-AMC
and Z-RR-AMC under the determined optimal pH con-
ditions (Fig. S6). The same amount of enzyme was incu-
bated with various concentrations of substrates,
ﬂuorescence units were recorded and the kinetic parame-
ters of the enzymes were calculated. The Km and Kcat/Km
values for the two ﬂuorescent substrates are presented in
Table 1. The results showed that CP16779 exhibited the
lowest Km values and highest Kcat/Km for the Z-FR-AMC
substrate. For the Z-RR-AMC substrate, the Km and
Kcat/Km values were very similar for the three enzymes
(Table 1), with the Km value for CP14019 being the low-
est. The three CPs have a preference for Z-FR-AMC over
Z-RR-AMC but the cleavage rates are more similar for
CP16160 (Fig. 3 and Fig. S6). These results show that
while the three enzymes can use similar substrates, the
reaction dynamics might vary between them, including
the amount of substrate required to reach the same reac-
tion speed and substrate preference.
The epithelial barrier breakdown by G. intestinalis
ESPs and recombinant cysteine proteases
Giardia trophozoites affect the integrity of the AJCs
between IECs and the tight junction proteins occludin
and claudin-1 and -4 have been shown to be delocalized
and/or degraded during host parasite interactions
[15,40]. It has also recently been shown that Giardia
ESPs bind to the intercellular junctions between IECs
[38]. To assess whether the interaction or binding of
ESPs to intercellular junctions affected their integrity,
IECs were exposed to ESPs (Fig. 4). We collected ESPs
from axenic cultures of WB trophozoites in a special
serum-free medium, which is optimized for trophozoite
viability (Materials and Methods). In the ﬁrst experi-
ments (Fig. 4A) the ESPs were concentrated and 1 and
5 mg /ml ESPs was added to the IECs in chamber slides.
Immunoﬂuorescence was used to identify structural
changes in the IEC intercellular junctions. The results
Figure 2. Localization of G. intestinalis cathepsin B-like cysteine proteases. The localization of 3xHA epitope-tagged cathepsin B-like cys-
teine proteases (CP14109, CP16160 and CP16779) by immunoﬂuorescence microscopy. Transfectants were detected with a mouse anti-
HA antibody conjugated to Alexa Fluor 488. Images were taken by a Zeiss Axioplan II Imaging ﬂuorescence microscope and analyzed by
ZEN 2.1 software. Bar = 10 mm.
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showed ﬂocculation and reorganization of ZO-1, occlu-
din and claudin-1 in IECs exposed to 1 and 5 mg (per
ml) of Giardia ESPs (Fig. 4A). Similar results were
obtained for occludin and claudin-1 after addition of
non-concentrated ESPs (Fig. 4B). We could also detect
changes in F-actin localization, whereas E-cadherin did
not change (Fig. 4B). This shows that the Giardia ESPs
affect AJCs between IECs.
To assess the effects of the three CPs on the AJCs, we
used Western blotting and immunoﬂuorescence to exam-
ine the degradation and distribution of junctional proteins
after treating Caco-2 cells with recombinant CPs. Recom-
binant CP14019 and CP16779 were able to degrade clau-
din-1 and -4 after 24 h of incubation with Caco-2 cells,
with the degradation being more pronounced at lower
enzyme concentrations (< 1 mg/ml) (Fig. 5A and B,
Fig. S7). Both CPs could also cause a slight degradation of
b-catenin, occludin and JAM-1, but the degradation pat-
tern was inconsistent with the amount of CPs added. No
clear changes in the levels of E-cadherin were seen with
both CPs. In the case of CP16160, the degradation of the
aforementioned junctional proteins occurred in a dose-
dependent manner (Fig. 5C, Fig. S7). Since we did not
reach a conclusive result on the ability of the CPs to
degrade E-cadherin, we tested their ability to directly
degrade human recombinant E-cadherin (rhE-cadherin)
using different concentrations of the proteases and incuba-
tion periods (Fig. S8). Here, we could clearly see the deg-
radation of rhE-cadherin at enzyme concentrations as low
as 0.05 mM and within 5 minutes incubation with this
protein. We could also show that recombinant occludin is
digested by the CPs (Fig. S9). Overall, the results show
that recombinant CPs are able to degrade junctional com-
plex proteins required for the integrity of the intestinal
epithelial barrier. The reduced digestion of certain AJC
proteins can be due to limited access of the recombinant
CPs to the proteins. Furthermore, immunoﬂuorescence
images showed reduced levels and re-localization of the
tight junction proteins occludin and claudin-4, as well as
the adherence junction proteins, E-cadherin and beta-cate-
nin, after 24 h of incubation with the recombinant CPs
(Fig. 5D–F, Fig. S10–S13). A disruption in the integrity of
Figure 3. Recombinant G. intestinalis secreted cysteine proteases were expressed, puriﬁed and characterized. (A) SDS-page gel showed
that both 14019 and 16779 were expressed as the mature form of 28 kDa whereas 16160 was expressed as a combination of a zymogen
of 35 kDa and a mature form of 28 kDa. 16160 auto-activated to the mature form after 120 min incubation in sodium acetate buffer (pH
5.5). (B-D) pH proﬁles of CP14019 (B), CP16779 (C) and CP16160 (D) against the ﬂuorogenic substrates Z-FR-AMC and Z-RR-AMC showed
that the pH optimum was 5.5-6.0 for activity against both substrates.
Table 1. Kinetics parameters for secreted cysteine proteases.
Recombinant enzymes were incubated with various concentra-
tions of ﬂuorogenic substrates under the optimal pH conditions
and ﬂuorescence units were recorded at 37C over time. Data
was calculated using Michaelis-Menten kinetics in the Graphpad
Prism 5.0 software.
Z-FR-AMC Z-RR-AMC
Enzyme Optimal
pH
Km
(mM)
Kcat/Km
(M¡1S¡1)
Optimal
pH
Km
(mM)
Kcat/Km
(M¡1S¡1)
CP14019 5.5 3.17§
0.34
(1.79»2.37)
X 105
5.5 5.11§
1.11
(5.41»9.84)
X 103
CP16779 6 0.96§
0.24
(1.02»2.06)
X 106
6 5.40§
0.75
(1.05»1.48)
X 104
CP16160 6 9.40§
1.46
(4.30»6.77)
X 104
5.5 5.60§
1.00
(5.86»9.61)
X 104
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the Caco-2 cell monolayer was also observed and these
effects were reduced with CPs inhibited by E-64 (Fig. S10–
S13). These ﬁndings indicate that the CPs released by
Giardia might play a role in compromising the integrity
of the intestinal epithelial barrier.
Chemokine degradation by ESPs and recombinant
CPs
Recent data have shown that CP activities from Giardia
can degrade chemokines like IL-8 and reduce inﬂamma-
tion [24]. To follow up this observation, we tested if
Giardia ESPs are capable of degrading cytokines/chemo-
kines that are induced during Giardia-IEC interactions
[41]. We incubated concentrated Giardia ESPs with dif-
ferent pure cytokines and chemokines and electrophor-
esed the reaction mixture on SDS-PAGE gels to visualise
potential degradation (Fig. 6A). Incubation of IL-8 with
1 mg of ESPs from each isolate resulted in the appearance
of fuzzy bands on stained gels (compared to control),
indicating their cleavage/partial degradation (Fig. 6A).
IL-8 degradation manifested clearly (i.e. fainter and fuzz-
ier bands) with increasing amounts of ESPs (5 mg and
10 mg, Fig. 6A). For CCL20, a fuzzy band could already
Figure 4. Effect of ESPs on apical junction complexes. A. Intestinal epithelial cells (Caco-2) were treated with 1 and 5 ug of concentrated
ESPs from Giardia WB trophozoites in axenic culture in serum-free medium. The localizations of Zonula Occludens-1 (ZO-1), Occludin
and Claudin-1 were studied using speciﬁc antibodies. B. Intestinal epithelial cells (Caco-2) treated with non-concentrated ESPs from Giar-
dia trophozoites in axenic cultures in serum-free medium. The localizations of Occludin, Claudin-1, E-cadherin and F-actin were studied
using speciﬁc antibodies. Images were taken by a Zeiss Axioplan II Imaging ﬂuorescence microscope and analyzed by ZEN 2.1 software.
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Figure 5. G. intestinalis secreted cysteine proteases have effects on epithelial barrier proteins. A, B, C. Levels of tight junction and adher-
ence junction proteins in Caco-2 whole cell extracts were examined after 24 h of recombinant cysteine proteases treatment (A, 14019;
B, 16779; C, 16160), respectively, by Western blot analysis, with GAPDH used as a loading control. Barrier proteins were detected with a
mouse or rabbit anti-barrier protein antibody and then incubated with a HR- conjugated mouse or rabbit antibody. D E, F. The localiza-
tion of occludin in Caco-2 cells visualized by immunoﬂuorescence microscopy. Caco-2 monolayers were incubated with 2.5 mg/ml of
14019 (D), 16779 (E), 16160 (F) in the absence or presence of E64 (10 mM) for 24 h, followed by ﬁxation of PFA. Occludin was detected
with a mouse anti-occludin antibody and then incubated with an Alexa Fluor 488-conjugated mouse antibody. Images were taken by a
Zeiss Axioplan II Imaging ﬂuorescence microscope and analyzed by ZEN 2.1 software. Bar = 50 mm.
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be seen upon incubation with ESPs of WB isolate (1mg)
and it increased with higher amounts of ESPs (Fig. 6A).
CXCL1 and TNF-a appeared as fuzzy bands upon incu-
bation with 1mg of ESPs from each isolate (i.e. partial
degradation) (Fig. 6A). ESPs of the WB isolate
completely degraded CXCL3 (Fig. 6A). These results
demonstrate that ESPs of Giardia are capable of degrad-
ing or cleaving different cytokines/chemokines. Thus,
Giardia ESPs might exert immunomodulatory functions
represented by the attenuation of inﬂammatory
responses induced by the chemokines produced by IECs.
To test whether the chemokines expressed by Caco-2
cells during Giardia infection [41] can be potential sub-
strates for CPs, we incubated 1 mg of chemokines with
active mature enzymes in the presence or absence of E-
64 and examined their cleavage/degradation by gel elec-
trophoresis (Fig. 6, Table S6). Both CP14019 and
CP16779 cleaved the chemokines, CXCL2, CCL20 and
CCL2 as evidenced by the appearance of two lower
molecular weight bands on the gel after protease treat-
ment compared to controls (i.e. untreated chemokines)
(Fig. 6B–D). In case of CXCL1, fuzzier bands appeared
on the gel indicating partial degradation whereas for IL-
8, a fuzzy lower molecular band appeared under the che-
mokine band indicating cleavage. No CXCL3 degrada-
tion could be seen with CP14019 and CP16779,
indicating substrate speciﬁcity in the mode of action of
the two CPs. In case of CP16160, all tested chemokines
were either degraded (e.g. CXCL1-3) or cleaved (e.g.
CCL2, CCL20 and IL-8) (Fig. 6B–D). For all the CPs
tested, E-64 treatment abolished their ability to degrade
the chemokines (Fig. 6B–D). While these results show
that Giardia CPs exhibit selectivity and differential abil-
ity to degrade inﬂammatory chemokines, they also high-
light the potential of Giardia released CPs to modulate
inﬂammatory responses.
Discussion
Cathepsin B-like protease activities from Giardia have
recently been shown to be important in host-pathogen
interactions in several different studies [23–27]. How-
ever, the speciﬁc proteases have not been identiﬁed.
Herein, we focused on three CPs that we identiﬁed in the
medium of Giardia-host cell interactions, characterized
them and identiﬁed their potential involvement in
Figure 6. G. intestinalis ESPs and cysteine proteases have a proteolytic effect on chemokines. A. Digestion of chemokines with ESPs col-
lected from axenic Giardia WB cultures. B-D. Cleavage of chemokines by recombinant cysteine proteases was performed as described in
Methods. 100 mM of E-64 was routinely added to the proteases for 30 min at 37C. Samples were analyzed by 16.5% Tris-Tricine gel
under reducing condition. represents “clear degradation of chemokines”, represents “uncertain cleavage of chemokines”.
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disease mechanisms. Our data suggest that the CPs are
involved in destruction of the intestinal epithelial barrier
and in chemokine degradation (Fig. 7).
First, we examined the proteolytic activity in the
medium of co-culture and compared the banding pattern
to that of axenic culture. We showed proteolytic bands
on zymogram gels with molecular weights ranging
between 20 and 200 kDa, with an increase in the inten-
sity of CP bands speciﬁcally on contact with IECs. Simi-
lar results were previously reported by Rodrıguez-
Fuentes et al. [18] who demonstrated that the released
CPs play a role in trophozoite attachment to IECs. Previ-
ous reports have shown the up-regulation of CP14019,
CP16779 and CP16160 at the RNA and protein levels
during host-parasite interaction in vitro and recently
they were shown to be released into the co-culture
medium [30–32,34,35,38,42]. Here we identiﬁed the
same CPs in the zymogram gel bands. Secretion is fur-
ther supported by the presence of secretion signal pepti-
des in these CPs and localization to vesicle-like
structures dispersed through the cytoplasm and ER,
which have been shown to be involved in protein uptake
and release [43].
To characterize the identiﬁed CPs, we used P. pastoris
as an expression system through which the proper condi-
tions required for enzyme activity (e.g. correct folding
and glycosylation) are attained. The CP14019 and
CP16779 auto-activated during the puriﬁcation process
whereas the CP16160 was present in both the zymogen
and active forms, which have been previously seen dur-
ing the proteolytic maturation of pro-cathepsins [44].
Activation occurs spontaneously or upon exposure to
acidic environment and it is mediated by the pro-peptide
functioning as a chaperon to assist protein folding and
controlling the protease activity [43,44]. The recombi-
nant CPs displayed an optimal activity at an acidic pH
(e.g. 5.5-6), the conventional pH for this class of enzymes
[29,37,45] and a preference for the ﬂuorescent substrate
FR-AMC. These attributes have been previously ascribed
to the conformational change in the binding site (i.e. S2
pocket, Fig. S4) upon enzyme maturation, the change in
the hydrogen ion concentration (i.e. pH) and/or the
activity of the mature enzyme being regulated by the
pro-peptide [29,39]. How these CPs behave when
released all together from Giardia upon contact with
host cell and how their interaction with each other and
host cells affect their activity is an interesting subject for
further research.
The maintenance of the intestinal epithelial barrier
integrity is of paramount importance to prevent to the
follow of microbes and antigens into the underlying tis-
sue [7,8]. This is achieved by forming a seal-like struc-
ture through the speciﬁc organization of AJC proteins.
Their arrangement, however, is reorganized during
microbial infections compromising the integrity of epi-
thelial barrier and increasing its permeability. This is the
case in Giardia infections where the re-arrangement of
ZO-1, a-actinin, occludin and F-actin has been reported
in in vitro studies together with the increase in the per-
meability of epithelial cell monolayer [13–16,22]. The
expression level of claudin-1, the transmembrane protein
responsible for the sealing properties of tight junctions,
decreased in chronic giardiasis patients [11]. Therefore,
it has become evident that Giardia infections affect the
integrity of intestinal epithelia by reorganizing proteins
of the AJCs. In this report, we provided a further insight
into the ability of Giardia ESPs, namely CPs, to replicate
these effects and expanded the range of apical junctional
complexes proteins affected by Giardia CPs to include
claudin-4, b-catenin and E-cadherin (Fig. 7). We also
showed that these effects are brought about by either the
degradation or re-distribution of the proteins above,
which overall disrupts the integrity of epithelial sheath.
Certain AJC proteins were less affected after addition of
recombinant proteins to the IECs compared to the deg-
radation of recombinant proteins (E-cadherin) or after
addition of parasites. The parasites attach strongly with
the adhesive disc [4] and it is possible that this interac-
tion contribute to the destruction of the AJCs. In con-
junction with results from previous reports [19,46,47]
showing that parasite CPs are capable of degrading a
wide range of substrates including collagen I, an
Figure 7. Model of cathepsin B cysteine proteases function dur-
ing Giardia-host cells interactions. Giardia cathepsin B cysteine
proteases released during host-parasite interaction have proteo-
lytic activity and are capable of destroying the junctional com-
plexes (TJs and AJs). The CPs can pass the epithelial barrier and
degrade chemokines that are induced by intestinal epithelial cells
and released on the basolateral side in response to Giardia
infection.
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important component of the extracellular cellular matrix,
these ﬁndings collectively indicate that Giardia CPs play
an important role in disease induction.
The genes encoding different chemokines are induced
in IECs upon Giardia infection in vitro [41]. The chemo-
kines induced include CCL2, CCL20 and CXCL1-3,
amongst which CCL20 exhibited the highest fold change
in RNA levels during the ﬁrst 90 minutes of interaction
[41]. This unique chemokine proﬁle targets different
populations of immune cells like dendritic cells, T cells,
and B cells by CCL20, neutrophils by CXCL1 to CXCL3,
and macrophages and T-cells by CCL2 to the site of
infection [41]. However, the amounts of CCL20 pro-
duced and released into the medium of interaction were
low (< 50 ng/ml) compared to the transcriptional level,
indicating post-transcriptional regulation of CCL20 lev-
els. In fact, a similar mechanism has been reported for
IL-8 in another study, where the degradation of IL-8 by
Giardia CPs resulted in the attenuation of neutrophil
chemotaxis in assays using a cell culture model of infec-
tion and ex vivo human biopsies [24]. Herein, we corrob-
orate the ﬁndings above by showing that the
recombinant CPs were able to cleave/degrade CCL20
and IL-8, an effect that was abolished by inhibiting CP
function with E-64 treatment. Not only this, but CCL2
and CXCL1-3 could also be cleaved/degraded by the
expressed CPs, although differences in substrate speciﬁc-
ities were observed (Fig. 7). The substrate speciﬁcity is
not uncommon and could be attributed to structural dif-
ferences between the recombinant CPs, as observed in
our structural analysis (File S1), hence their ability to
interact with different substrates. In Entamoeba histoly-
tica, CPs are important for pathogenesis and a recombi-
nant CP, named EhCP2, was able to cleave the
chemokines CCL-2, CCL-13 and IL-8, impairing their
function in chemotaxis assays with monocytes and gran-
ulocytes [45,48]. Despite this, it is worth noting that
EhCP2 had an opposite effect on a less active variant
form of IL-8 that has 5 extra amino acid residues in the
N-terminal sequence [48]. This could also imply that
some CPs contribute in the maturation of certain cyto-
kines and thus favoring the induction of pro-inﬂamma-
tory microenvironment for nutrient acquisition and
dissemination. It will be interesting to identify the cleav-
age motifs for the CPs above and test whether the cleaved
chemokines become ineffective in chemotaxis to fully
assess the impact of Giardia CPs on modulation of
immune response. Combining the data from studies of
CP degradation of junctional proteins with the data from
chemokine degradation makes it possible to propose a
model (Fig. 7) for how the combined activities can inter-
act to reduce the effect of chemokines that are induced
in IECs during host parasite interactions. The model can
partly explain the low levels of inﬂammation seen during
giardiasis [49–51] and it can also explain the observed
problems with the epithelial barrier during giardiasis [8].
Thus, at the same times as the parasite reduces inﬂam-
mation it can also create diarrhea and post-infectious
problems like inﬂammatory bowel syndrome (IBS) and
food allergies. This suggests that the identiﬁed CPs are
key virulence factors in Giardia.
In summary, we have identiﬁed and expressed the three
main CPs released by Giardia during interaction with host
intestinal epithelial cells in vitro. The recombinant CPs dis-
played characteristics of cathepsin B in terms of their activ-
ity and varied in their kinetics and substrate preference.
The expressed CPs were able to degrade and reorganize
junctional proteins and degrade a range of chemokines,
indicating potential roles in the disruption of intestinal epi-
thelial barrier and immune modulation. Further studies
will focus on characterizing these proteases in Giardia dur-
ing infections in animal models and humans and it can
hopefully identify their speciﬁc role in disease.
Materials and methods
Parasite cultivation and cell culture
G. intestinalis isolates, WB clone C6 (ATCC number
50803, assemblage A) and GS (ATCC number 50581,
assemblage B), were used in this study. Trophozoites of
each isolate were propagated in modiﬁed TYI-S-33
medium [52] supplemented with 10% heat inactivated
bovine serum (Gibco, cat no. 26170043) at 37C until
reaching 80% conﬂuence, then used in the experiments.
The human intestinal epithelial colorectal adenocarci-
noma cell line, Caco-2 (ATCC HTB-37, passage no.
10–16), was cultured and maintained in Dulbeccos mod-
iﬁed Eagles medium (DMEM) (Sigma-Aldrich, cat no.
D6546) supplemented with 10% heat-inactivated fetal
bovine serum (HI-FBS) (Thermo Fisher Scientiﬁc, cat
no. 10100147), 100 mg/ml streptomycin and 100 U/ml
penicillin (Thermo Fisher Scientiﬁc, cat no. P0781),
200 mM L-glutamine (Thermo Fisher Scientiﬁc, cat no.
35050061) and 100 mM non-essential amino acids
(Sigma-Aldrich, cat no. M7145). Cells were seeded into
T25 tissue culture ﬂasks (Sarstedt, cat no. 83.3910, 12-
well plates (Corning, cat no. 3513) and Nunc Lab-Tek II
Chamber Slide (Sigma-Aldrich, cat no. C7057) and incu-
bated in complete DMEM. Cells in T25 ﬂasks were left
to differentiate for 14–21 days post-conﬂuence and the
12-well plates and chamber slides were maintained for
3 days post conﬂuence before being used in the experi-
ments. For all cell cultures, the media were changed twice
weekly and incubated at 37C in a 10% CO2 humidiﬁed
tissue culture incubator.
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Collection Giardia excretory-secretory products
(ESPs)
To collect Giardia ESPs, TYI-S-33 media in axenic
cultures (48 h) were decanted and the tubes were
washed three times with warm PBS to remove non-
attached or dead trophozoites. Thereafter, tubes with
adherent trophozoites were replenished with serum-
free M199 medium (Thermo Fisher Scientiﬁc, cat no.
11043023) supplemented with 6 mM ascorbic acid
(Sigma-Aldrich, cat no. A4544) and 6 mM L-cysteine
(Sigma-Aldrich, cat no. C7880) (pH 7.2, at 37C) and
incubated for 2 h and 6 h. To collect ESPs in co-cul-
ture with Caco-2 cells, parasite cultures were treated
as above but with the inclusion of cold shock step
(i.e. wet ice) to detach trophozoites for cell counting
and resuspension in the media above. Trophozoites
were added to pre-washed Caco-2 culture ﬂasks (3 x,
warm PBS) in a 3:1 (parasite: IECs) ratio and incu-
bated in a tissue culture incubator for 2 h and 6 h
(37C, 10% CO2). Incubation of trophozoites and
IECs in the modiﬁed M199 medium did not affect
their viability as reported in [32]. In the end of all
incubations, culture media were collected and centri-
fuged at 500 £ g for 10 min at 4C to pellet tropho-
zoites and the supernatants were ﬁltered sterilized
(0.22 mm) and concentrated using Amicon Ultra-15
Centrifugal Filter Units (Merck Millipore, cat no.
UFC900308) with a 3 kDa cut-off. The concentrates
were aliquoted and stored at ¡80C until use. It
should be noted that this isolation method of ESPs
also enrich for released vesicles like exosomes and
microvesicles [38].
Detection of protease activity using gelatin
zymograms
Before running samples on a zymogram gel, protein con-
centration was estimated using Qubit protein assay
(Thermo Fisher Scientiﬁc, cat no. Q33211) according to
the manufacturer’s protocol. Brieﬂy, ESP samples (30 mg
each) were incubated with an equal volume of non-
reducing electrophoresis buffer for 15 min at room tem-
perature then loaded into a 10% SDS-PAGE gels copoly-
merized with 0.1% gelatin and electrophoresed at 100 V,
4C (non-reducing conditions) until the dye reached the
bottom of the gel. Gels were washed three times for
15 min in 2.5% Triton X-100 solution (Sigma-Aldrich,
cat no. X100), followed by incubation in a zymogram
developing buffer (Thermo Fisher Scientiﬁc, cat no.
LC2671) overnight at 37C. Next day, gels were stained
with Coomassie Blue and destained in water. Proteases
appeared as white bands against a blue background. To
identify CPs, samples were treated with 100 mM of
trans-Epoxysuccinyl-L-leucylamido (4-guanidino)butane
(E64) (Sigma-Aldrich, cat no. E3132-1MG) for 30 min at
37C before running on the zymogram gel. CPs were
identiﬁed by the inhibition of protease band activities
when compared to untreated gels. Bands identiﬁed with
CPs were excised from the gels and sent for mass spec-
trophotometry analysis to identify corresponding
peptides.
Cysteine protease bands and mass spectrometry
analysis
Proteomics was performed essentially as described earlier
[38]. Proteins were reduced, alkylated and in-gel digested
by trypsin, dried and resolved in 15 mL 0.1% FA (formic
acid). Peptides were separated in reversed-phase on a
C18-column and electrosprayed on-line to an LTQ Orbi-
trap Velos Pro ETD mass spectrometer (Thermo Finni-
gan). Tandem mass spectrometry was performed
applying CID and it was performed at proteomics core
facility at SciLifelab, Uppsala, Sweden.
Database searches were performed using the Sequest
algorithm, embedded in Proteome Discoverer 1.4
(Thermo Fisher Scientiﬁc), towards a FASTA database
containing proteins from Giardia, downloaded from
giardiadb.org/common/downloads/release5.0/Gintesti-
nalisAssemblageA/. The search criteria for protein iden-
tiﬁcation were set to at least one matching peptide of
95% conﬁdence level per protein. In addition, database
searches against human proteins in Swissprot were per-
formed in order to identify possible contaminations.
Cloning of cysteine proteases into plasmids
and transfection
Genes were ampliﬁed with their endogenous promoter
regions using the forward primer 14019-5 0: CCCACGCGT-
CAAACTCTTCACAGAGGCCGCCTGGATCC and the
reverse primer 14019-3 0: GGGCGGCCGCTCATCGAA-
GAAGCCCGCATAGGCCTGC, the forward primer
16160–5 0: GGTCTAGACAGGCAAGTGAAGAAACCGC
and the reverse primer 16160–3 0: CCGCGGCCGCTCT
ACGTCTGCATAGTGGAAGCC, the forward primer
16779-5 0: CCCACGCGTGACACCAAGTTGTGTCTTC
CTGTAGG and the reverse primer 16779-3 0: G
GGCGGCCGCTTCTCAAAGAACCCACCTATTACTTG
C, and cloned into the episomal pPAC-3xHA-C vector53
using Xba I/Not I restriction sites for CP16160 and MluI/
NotI restriction sites for CP14019 and CP16779. Electropo-
ration was performed as described in [53]. Transgenic para-
sites were selected by the addition of puromycin (50 mg/ml)
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approximately 16 h after transfection and stable transfec-
tants were generally obtained after a week.
Localization of cysteine proteases
Transfected cells were prepared for immunoﬂuorescence
microscopy as described [54] with some adjustment.
Brieﬂy, trophozoites were harvested by chilling on ice for
10 min, washed twice in ice-cold PBS, and ﬁxed with 2%
paraformaldehyde (PFA) (Thermo Fisher Scientiﬁc, cat
no. 28906) at 37C for 20 min in a pre-warmed moisture
chamber, followed by 10 min washing in 100 mM glycine
prepared in PBS. Fixed cells were permeabilized with
0.2% Triton X-100 (Sigma-Aldrich, cat no. X100) in PBS
for 30 min and blocked at room temperature for 1 h in
2% bovine serum albumin (BSA) (VWR, cat no.
441555J) prepared in PBS. The anti-HA mouse mono-
clonal antibody conjugated to Alexa ﬂuor 488 (BioLe-
gend) was diluted 1:250 in PBS containing 2% BSA and
0.05% Triton X-100 (Sigma-Aldrich), incubated with
ﬁxed cells for 1 h at room temperature. Images were
taken using a Zeiss Axioplan II Imaging ﬂuorescence
microscope (Carl Zeiss Light Microscopy, ZEISS) and
analyzed by ZEN 2.1 software.
Transformation and expression of secreted CPs
in Pichia pastoris
The CP14019, CP16160 and CP16779 genes were ampli-
ﬁed by PCR from genomic DNA extracted from Giardia
WB isolate using the forward primer 14019-5 0:
GGGAATTCGAGCTTAACCACATCAAGTCCC and the
reverse primer 14019-3 0: CCTCTAGATCAATGATGAT-
GATGATGATGCTCATCGAAGAAGCCCGCATAGG,
the forward primer 16160–5 0: GGGAATTCTCTTTG
TCCGCGCTACCTCTCA and the reverse primer 16160–
3 0: CCTCTAGATCAATGATGATGATGATGATGCTC
TACGTCTGCATAGTGGAAGCC, the forward primer
16779-5 0: GGGAATTCGAGCTTAACCACATCAAGTC
CCTGAATCCC and the reverse primer 16779-3 0:
CCTCTAGATCAATGATGATGATGATGATGGTTCTC
AAAGAACCCACCTATTACTTG. The amplicons were
cloned into the EcoR I/Xba I sites of the Pichia pastoris
expression vector pPICZaA in frame with a poly-histidine
tag added to the C-terminal. The plasmids were linearized
by Sac I or BstX I and introduced into P. pastoris by elec-
troporation (GenePulser XCell, Bio-Rad) according to the
provider’s protocol. Transfectants were screened by
growth on YPD + 200 mg/ml of Zeocin (Thermo Fisher
Scientiﬁc, cat no. R25005) and conﬁrmed by Sanger
sequencing.
Puriﬁcation of CP14019, CP16160 and CP16779
Proteins expression was induced in P. pastoris growth
during under 3 days period during which 100% metha-
nol was added every 24 h to maintain protein expression
(0.5% methanol ﬁnal concentration). After 72 hours, cul-
ture supernatants were collected and ﬁltered using
0.2 mm ﬁltration units. Recombinant proteins were puri-
ﬁed using Nickle-resin columns (Thermo Fisher Scien-
tiﬁc, cat no. 88222) followed by desalting. Protein
concentrations were determined by Bradford Assay (Bio-
Rad, cat. no. 5000205) and puriﬁed proteins were ali-
quoted and stored at ¡80C until use.
Detection of cathepsin cysteine protease activity
The activity of recombinant proteins was determined by
measuring their ability to cleave the ﬂuorogenic sub-
strates N-carbobenzoxy-phenylalanyl-arginyl-7-amido-
4-methylcoumarin (Z-FR-AMC) and N-carbobenzoxy-
arginyl-arginyl-7-amido-4-methylcoumarin (Z-RR-
AMC) (Bachem, cat no. I-1160 and I-1135). The sub-
strates were incubated with recombinant proteins in
sodium acetate buffers (pH 4.0-5.5) or basic/dibasic
sodium phosphate buffers (pH 6.0-8.0) containing 4 mM
DTT and 10 mM EDTA. Protein activity was measured
by monitoring the increase in relative ﬂuorescence units
(RFU) over time at 37C using an excitation wavelength
of 360 nm and an emission wavelength of 470 nm. For
CP16160, recombinant protein was pre-activated in a
sodium acetate buffer for 120 min (pH 5.5 at 37C) prior
to starting the assay.
To determine the Km and Kcat/Km of the enzymes, the
ﬂuorogenic substrates Z-FR-AMC and Z-RR-AMC were
incubated with the enzymes separately at a range of con-
centrations under the optimum pH condition and the
velocity of these reactions was used to calculate the Km
and Kcat/Km. Data were analyzed using the Michaelis-
Menten model (Prism 5 software, Graphpad).
Effects of ESPs and recombinant CPs on AJC proteins
Chamber slides with differentiated Caco-2 cells were
used to assess the effect of ESPs on AJC proteins. Brieﬂy,
IECs grown in Nunc Lab-Tek II chamber slides were
washed (2x, PBS) and incubated with fresh complete
DMEM (1 h), followed by the addition of media contain-
ing ESPs from axenic cultures and further incubation for
6 h (37C, 10% CO2). Concentrated ESPs from axenic
cultures were quantiﬁed using the Qubit protein reagent
and added to IECs at 1, 5 or 10 mg/ml. At 6 h, IECs were
washed with PBS and ﬁxed with 4% paraformaldehyde
prepared in PBS (Pierce, Thermo Fisher Scientiﬁc) for
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15 min at RT. Fixative was washed off (3x, PBS) and
IECs were blocked for 1 h at RT (1x PBS, 5% normal
goat serum, 0.3% TritonTM X-100). After blocking, IECs
were incubated for 4 h with Alexa Fluor 488 conjugated
anti ZO-1, claudin-1, or occludin (dilution 1:100 in PBS
with 1% BSA and 0.3% Triton X-100) or overnight with
unconjugated primary antibodies against E-cadherin.
Next day, upon washing the slides (3x, PBS), those incu-
bated with unconjugated primary antibodies were
probed with either a secondary anti-rabbit or anti-mouse
Alexa Fluor 488 or Alexa Fluor 546 conjugated antibody
and ActinRed 555 ReadyProbes Reagent for actin stain-
ing (Molecular Probes, Thermo Fisher Scientiﬁc). All
antibodies were purchased from Thermo Fisher Scien-
tiﬁc, Claudin-1 cat no. 37–4900, Occludin cat no. 33–
1500, E-cadherin cat. no. PA5-32178. Cells were washed
with PBS containing a DAPI nuclear stain (Vector, cat
no. H1200) and mounted using the VectaShield reagents
(Vector, cat no. H1200). Images were taken using a
Zeiss Axioplan II Imaging ﬂuorescence microscope (Carl
Zeiss Light Microscopy, ZEISS) and analyzed by ZEN 2.1
software.
Recombinant CPs (2.5 mg/ml) were each added to
Caco-2 cells in the presence or absence of E64 (10 mM)
and a control (Caco-2 cells in DMEM without the CPs)
and incubated at 37C for 24 h (10% CO2). Next day,
cells were washed with PBS and ﬁxed in 4% PFA pre-
pared in PBS at room temperature for 15 min. Following
ﬁxation, cells were washed with PBS (3x), and blocked in
3% BSA in PBS at room temperature for 1 h. Cells were
incubated over night with primary antibodies against
occludin (1:100), claudin-4 (1:100), E-cadherin (1:100)
and beta-catenin (1:50), all diluted in the blocking solu-
tion (3% BSA in PBS). Then, cells were washed with PBS
(3x) and incubated with AlexaFluor 488 or Alexaﬂuor-
594-conjugated anti-rabbit or anti-mouse antibodies
(1:200) (Thermo Fisher Scientiﬁc, cat no. A11008,
A11029, A21207, A11005), at room temperature for 1 h.
Cells were mounted and imaged as above.
Western blot analysis of the effect of recombinant
CPs on AJCs
Recombinant CPs (CP14019, CP16160 and CP16779)
were added separately to Caco-2 cells at different con-
centrations (0–30 mg/ml) and incubated for 24 h at 37C
(10% CO2). Cells incubated in media alone served as a
negative control. Next day, Caco-2 cells were washed
twice with PBS, scraped off and the cell suspension was
centrifuged (10 min at 500 £ g, at 4C) to pellet the cells
for whole protein extraction. Pelleted cells were lyzed in
NP-40 lysis buffer (Thermo Fisher Scientiﬁc, cat no.
FNN0021) supplemented with Halt Protease Inhibitor
Cocktail (Thermo Fisher, cat no. 78439) and stored at
-80C until use. Protein concentration was determined
using the Bradford assay (Bio-Rad, cat no. 5000205) and
equal amount of Caco-2 cell lysates (20 mg) were sepa-
rated under reducing conditions on Any kDa Precast
Tris-glycine gels (Bio-Rad, cat no. 4568123). Following
SDS-PAGE, proteins were transferred to a nitrocellulose
membrane (Pall Life Sciences, cat no. BSP0161) at 100 v
for 1 h and blocked in Tris-buffered Saline containing
0.1% Tween-20 (TBST) and 3% BSA for 1 h at room
temperature. Membranes were incubated overnight at
4C with primary antibodies against Claudin-4 (1:5000
dilution), Occludin, E-cadherin, b-catenin (all at 1:2500
dilution), JAM-1 (1:10000) and GAPDH (dilution). All
antibodies were purchased from Thermo Fisher Scien-
tiﬁc, Claudin-1 cat no. 37–4900, Claudin-4 cat no. 32–
9400, Occludin cat no. 33–1500, E-cadherin cat. no.
PA5-32178, b-catenin cat no. 71–2700, JAM-1 cat no.
36–1700, GAPDH cat no. PA1-987 and MA5-15738.
Next day membranes were washed three times in TBST
and incubated with anti-rabbit or anti-mouse HRP-con-
jugated secondary antibodies (1:10000) and developed
using the ECL kit (Bio-Rad, cat no. 170–5061). Mem-
branes Signals were detected using a ChemiDoc MP Sys-
tem (Bio-Rad) and protein abundance was quantiﬁed
using the ImageJ software and GAPDH as a loading
control.
In vitro degradation of rhEcadherin and rhOccludin
To test the direct proteolytic activity of CPs, different
concentrations of mature recombinant proteins were
each incubated with the recombinant human E-cadherin
protein (rhE-cadherin; Advanced BioMatrix, cat no.
5085-0.1 MG) for up to 1 h at 37C. Reaction mixtures
contained 1 mg of recombinant E-cadherin and 200 nM
of each CP, incubated for 0, 5, 10, 30, and 60 min. In
addition, parallel reactions were prepared in which CPs
were treated with 100 mM of E64 at 37C for 30 min
before incubation with rhE-cadherin. Samples were then
separated under reducing conditions on any kDa precast
Tris-glycine gels (Bio-Rad). To test the direct proteolytic
activity of CPs on Occludin, 200 ng mature recombinant
proteins were each incubated with 800 ng recombinant
human Occludin protein (rhOccludin; Abcam, cat no.
ab114189) for 30 min at 37C. Parallel reactions were
prepared in which CPs were treated with 100 mM of E64
at 37C for 30 min before incubation with rhOccludin.
Reactions were stopped by Laemmli sample buffer sup-
plemented with beta-mercaptoethanol. Samples were
analyzed by 4–12% bis-tris gels (Thermo Fisher Scien-
tiﬁc, cat no. NP0329BOX) under reducing conditions.
All gels were stained with QC Colloidal Coomassie Blue
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(Bio-Rad, cat no. 1610803) and visualized using a Chem-
iDoc MP System (Biorad).
Proteolytic cleavage of chemokines
A range of proinﬂammatory cytokines and chemokines
were incubated with Giardia ESPs to determine ESPs’
ability to modulate immune response represented by
cytokine degradation. The human recombinant cyto-
kines Interlukin-8 (IL-8), chemokine ligand-20 (CCL20)
and TNF-a were purchased from Sigma-Aldrich whereas
chemokine ligand 1 and 3 (CXCL1 and CXCL3) as well
as interleukin 1-alpha (IL-1-a) were purchased from
R&D Signaling (R&D Systems). All cytokines were sus-
pended in a sterile PBS at a concentration of 100 ng/ml.
ESPs were collected from trophozoites in axenic culture
in serum-free medium as described earlier and were
quantiﬁed for total proteins using the Qubit protein
assay reagent (Thermo Fisher Scientiﬁc). Next, 1mg of
ESPs, from each isolate, was mixed with each one of the
cytokines above and incubated at 37C for 1 h. Cytokines
or ESPs incubated alone were used as controls. For IL-8
and CCL20 only, we tested the effect of increasing ESPs
concentration (1, 5 and 10 mg) or incubation time (1 h
and 2 h) on cytokine degradation. At the end of all incu-
bations, samples were mixed with Laemmli sample
buffer, boiled for 5 min, cooled on ice and loaded onto
Any kDTM Mini-PROTEAN® TGX Stain-FreeTM Protein
Gels (Bio-Rad) alongside SpectraTM Multicolor Broad
Range Protein Ladder (Thermo Fisher Scientiﬁc). Gels
were electrophoresed at 100 volts until the dye reached
the bottom of the gel. Gels were ﬁxed and stained using a
QC Colloidal Commassie Stain (Bio-Rad) and visualised
using a ChemiDoc Imaging System (BioRad).
Recombinant CPs were incubated with similar set of
chemokines to test for chemokine degradation. The
recombinant CPs (500 ng) were activated as described
before (see the detection of cathepsin cysteine protease
activity section) and incubated with 1 mg of recombinant
human CXCL1, CXCL2, CXCL3, and CCL20 (Peprotech,
CXCL1, cat no. 300–11, CXCL2, cat no. 300–39, CXCL3,
cat no. 300–40, CCL20, cat no. 300–29A) for 60 min. For
CCL2 and IL-8 (Peprotech, cat no. CCL2, cat no. 300–
04, IL-8, cat no. 200–08 M), 1 mg of each was incubated
with 500 ng of 14019 and 16779 for different durations
ranging from 0 to 15 min. All reactions included chemo-
kines with no CPs as a negative control. Parallel reactions
with CPs treated with E-64 (100 mM) for 30 min (37C)
were setup as controls on CPs activity. At the end of all
incubations, the reactions were stopped by the addition
of 4 x Laemmlis sample buffer (Bio-Rad, cat no.
1610747) and heating at 95C for 5 min. Samples were
electrophoresed on a 16.5% Tris-Tricine SDS-PAGE
(Bio-Rad, cat no. 4563063) under reducing condition,
and stained by QC Colloidal Coomassie Blue (Bio-Rad).
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